NSCLC

Predicted combination treatments for NSCLC using in silico CRISPR screening
Lung cancer is the leading cause of cancer mortality world-wide, with over half of lung cancer patients relying on radiotherapy (RT). …
May 1, 2024 Kennedy Lecture Theatre, UCL Great Ormond Street Institute of Child Health
Matthew A. Clarke, Charles Barker, Ashley Nicholls, Matt Handler, Lisa Pickard, Saif Ahmad, Udai Banerji, Jyoti Choudhary, Gregory J. Hannon, Jasmin Fisher
Project Project Project
Predicted combination treatments for NSCLC using in silico CRISPR screening
Predicted combination treatments for NSCLC using in silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, with over half of lung cancer patients relying on radiotherapy (RT). …
Feb 27, 2024 — Feb 28, 2024 The Discovery Centre,
Matthew A. Clarke, Charles Barker, Ashley Nicholls, Matt Handler, Lisa Pickard, Saif Ahmad, Udai Banerji, Jyoti Choudhary, Gregory J. Hannon, Jasmin Fisher
Project Project Project
Predicted combination treatments for NSCLC using in silico CRISPR screens
Predicted radio-sensitising combination treatments for NSCLC using in-silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, with over half of lung cancer patients relying on radiotherapy (RT). …
Nov 3, 2023 Cancer Research UK Cambridge Institute
Matthew A. Clarke, Ashley Nicholls, Charles Barker, Matt Handler, Saif Ahmad, Gregory J. Hannon, Jasmin Fisher
Project Project
Predicted radio-sensitising combination treatments for NSCLC using in-silico CRISPR screens
Targeted radio-sensitising combination treatments for NSCLC using in silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, with over half of lung cancer patients relying on radiotherapy (RT). …
Oct 8, 2023 The Francis Crick Institute
Matthew A. Clarke, Ashley Nicholls, Charles Barker, Matt Handler, Saif Ahmad, Gregory J. Hannon, Jasmin Fisher
Project Project
Targeted radio-sensitising combination treatments for NSCLC using in silico CRISPR screens
Radiosensitising combination treatments for NSCLC using in silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, and over half of lung cancer patients rely on radiotherapy (RT). …
Jun 30, 2023 Royal College of General Practitioners
Matthew A. Clarke, Ashley Nicholls, Matt Handler, Saif Ahmad, Gregory J. Hannon, Jasmin Fisher
Project Project
Radiosensitising combination treatments for NSCLC using in silico CRISPR screens
Radio-sensitising combination treatments for NSCLC using in silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, and over half of lung cancer patients rely on radiotherapy (RT). …
Jun 19, 2023 Francis Crick Institute
Matthew A. Clarke, Ashley Nicholls, Matt Handler, Saif Ahmad, Gregory J. Hannon, Jasmin Fisher
Project Project
Radio-sensitising combination treatments for NSCLC using in silico CRISPR screens
Radio-sensitising combination treatments in NSCLC using in silico CRISPR screens
Lung cancer is the leading cause of cancer mortality world-wide, and over half of lung cancer patients rely on radiotherapy (RT). …
Jun 3, 2023 — Jun 6, 2023 University of Glasgow
Matthew A. Clarke, Ashley Nicholls, Matt Handler, Saif Ahmad, Gregory J. Hannon, Jasmin Fisher
Project Project
Radio-sensitising combination treatments in NSCLC using in silico CRISPR screens